InvestorsHub Logo
Followers 25
Posts 7029
Boards Moderated 2
Alias Born 06/11/2020

Re: J2003 post# 13392

Tuesday, 04/30/2024 8:49:33 AM

Tuesday, April 30, 2024 8:49:33 AM

Post# of 14071
I detailed what you have been seeing through Q1 2024 in my post# 7526 on December 19th just before this got hammered. It could have easily taken longer and may still be ongoing because of the 4.99% equity blocker restricting how many shares can be held at once. The March 22nd infomercial was very successful with 119 million shares traded but the April 10 infomercial was a bust with less than 3.5 million shares traded. One lender, 1800 Diagonal Lending LLC, held claim to roughly 600 million of the 698 total for the period so they were in control and being patient while this CEO rolled out the infomercials would have maximized their return.

When we compare the two statements from the 2023 annual and the Q3 2023 filing we see that 300,124,013 shares were added in Q4 2023. If we are to believe the securities details on the OTC site those shares were issued after December 22nd 2023. So start the 180 day clock and those unregistered shares would begin to vest at the end of June. Now add in the 195,620,499 shares issued for the lawsuit to GS Capital so far for 2024. All these unregistered shares should be observing the 180 day holding period so you can see that the second half of 2024 is going to get very busy.

What could still be available to convert between now and the end of June isn't clear. We know that a Form D was filed in may 2023 for $125K with a first sale date of March 2023 indicated in the filing. We do have 52,916,867 restricted shares as of December 22nd before the restricted increased to 206,266,867 on January 5th. The restricted number has remained unchanged as of the latest update of April 12th. The 52,916,867 could be eligible to be sold now at any time.

Bubae
Re: burner67 post# 7507
Tuesday, December 19, 2023 5:10:03 AM
Post# 7526 of 13395
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173456355

We are looking at 454,279,436 new shares issued between June 14th and September 30th. From comments on this board we know that the outstanding share count has been static for October and November. These shares were issued in a series of tranches through this period with an average price of roughly $0.00017. Consider the six month holding period and we find that these shares should become eligible soon on a rolling basis through Q1 2024. Now, there is also the other conversions in the pipe line with the offerings right? Exactly the kind of activity that drove the trading to $0.0001 in October.

Bubae
Re: NorthPeak22 post# 4462
Monday, December 11, 2023 6:23:38 PM
Post# 6659 of 13395
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173407134

Now consider that I also estimate that by next week the balance of roughly 454,279,436 of that group will become eligible on a rolling basis over the next three months.

For the fiscal year ended December 31, 2023
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001483646/000106594924000044/begi-20231231.htm

Page F-11
NOTE 5 – STOCKHOLDERS’ DEFICIT (continued)
Common Stock

During the year ended December 31, 2023, the Company issued shares of its common stock as follows:


  • 845,162,311 shares for conversion of $200,432 principal and interest on convertible note payable.
  • 71,250,000 shares valued at $266,063 as consideration for financing fees for loans made to the Company.
  • 25,000,000 shares valued at $100,000 ($0.004 per share) as partial consideration for a media consulting contract.
  • 56,788,923 shares for exercise of previously issued warrants at $0.0128 per share. The exercise price was revised to $0.00062 per share from $0.25 per share as per antidilution provision of the warrant agreement....


NOTE 12 – SUBSEQUENT EVENTS

In 2024, GS Capital filed notices of conversion and were issued, in three tranches, 195,620,499 shares of the Company’s common stock at a price of $0.00006 per share on their note of October 11, 2021. (See Notes 7 and 11)


For the quarterly period ended September 30, 2023
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001483646/000106594923000100/begi-20230930.htm

Page 10
NOTE 5 – STOCKHOLDERS’ DEFICIT
Common Stock

During the nine months ended September 30, 2023, the Company issued shares of its common stock as follows:


  • 698,077,221 shares for conversion of $116,725 principal and interest on convertible notes payable.





Bearish
Bearish

Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BEGI News